Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of oral tegafur versus capecitabine in advanced pretreated metastatic breast cancer
2004-004212-23Phase 4Active
- Sponsor
- Unidad Integral de Investigación en OncologÃa, S.L.
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in breast cancer comparing Oral tegafur with Oral capecitabine (2 arms). Primary endpoint: Time to progression. Started Dec 2005; status: active.
02
Drugs
tegafurcapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-004212-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004212-23.